Ignite Creation Date:
2025-12-24 @ 3:00 PM
Ignite Modification Date:
2026-02-02 @ 5:11 PM
Study NCT ID:
NCT01238159
Status:
COMPLETED
Last Update Posted:
2015-03-03
First Post:
2010-09-08
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Concomitant Chemo-radiotherapy Followed by MIDLE Chemotherapy in Stage I/II Extranodal NK/T-cell Lymphoma
Sponsor:
Samsung Medical Center
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Extranodal NK-T-Cell Lymphoma, Nasal and Nasal-Type | View |